Bamethan
Chemical compound
- C04AA31 (WHO)
- AU: S4 (Prescription only)
- 1-(p-hydroxyphenol)-2-butylamino-1-ethanol
- 3703-79-5
N
- 2292
- 2204
Y
- Y08ZFJ9TFK
- ChEMBL1987462
N
- DTXSID5046144
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- OC(c1ccc(O)cc1)CNCCCC
InChI
- InChI=1S/C12H19NO2/c1-2-3-8-13-9-12(15)10-4-6-11(14)7-5-10/h4-7,12-15H,2-3,8-9H2,1H3
Y
- Key:RDUHXGIIUDVSHR-UHFFFAOYSA-N
Y
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Bamethan is a vasodilator.[1]: 94
- v
- t
- e
Peripheral vasodilators (C04)
- Isoxsuprine
- Buphenine
- Bamethan
- Non-selective
- Selective α1-blockers
References
- ^ British Medical Association, Pharmaceutical Society of Great Britain. (1987). British National Formulary. Vol. 11. Pharmaceutical Press. ISBN 978-0-85369-191-4.
![]() | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e